Literature DB >> 12707075

Phenotypical features of a Moroccan family with autosomal recessive Charcot-Marie-Tooth disease associated with the S194X mutation in the GDAP1 gene.

Nazha Birouk1, Hamid Azzedine, Odile Dubourg, Marie-Paule Muriel, Ali Benomar, Tarik Hamadouche, Thierry Maisonobe, Reda Ouazzani, Alexis Brice, Mohamed Yahyaoui, Taïb Chkili, Eric Le Guern.   

Abstract

BACKGROUND: The first locus for demyelinating autosomal recessive Charcot-Marie-Tooth (ARCMT) disease was identified in 8q13, where mutations in GDAP1 have been found. Mutations in the same gene have been detected in families with axonal ARCMT disease.
OBJECTIVE: To determine the clinical, electrophysiologic, and morphologic characteristics of a consanguineous Moroccan family with ARCMT disease associated with the S194X mutation in the GDAP1 gene.
METHODS: Four patients from a consanguineous Moroccan family were examined clinically and electrophysiologically. In one patient, a morphometric and ultrastructural study of a peroneal nerve biopsy sample was performed. Mutation in the coding region of the GDAP1 gene was identified by direct sequencing.
RESULTS: Neuropathy was evident early in childhood, walking was delayed in one patient, and onset of symptoms occurred before 18 months in the others. The phenotype was severe: foot deformities and disabilities involving the hands and feet developed toward the end of the first decade, followed by involvement of proximal muscles in the lower limbs, leading to loss of autonomy. Electrophysiologic findings were consistent with an axonal form of CMT disease: motor nerve conduction velocities, recordable in one patient only, were greater than 40 m/sec. Sensory nerve action potentials were either abolished or substantially reduced in amplitude. The morphologic data supported the diagnosis of axonal neuropathy, showing a marked reduction in myelinated fibers and signs of axonal regeneration, including frequent pseudo-onion bulb formations. The 4 patients in this family were homozygous for the S194X mutation in the GDAP1 gene.
CONCLUSION: Electrophysiologic and pathological findings support the hypothesis of an axonal disorder in this ARCMT family with the S194X mutation in the GDAP1 gene.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12707075     DOI: 10.1001/archneur.60.4.598

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  15 in total

Review 1.  Molecular genetics of autosomal-recessive axonal Charcot-Marie-Tooth neuropathies.

Authors:  Rafaëlle Bernard; Annachiara De Sandre-Giovannoli; Valérie Delague; Nicolas Lévy
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 2.  Intermediate forms of Charcot-Marie-Tooth neuropathy: a review.

Authors:  Garth Nicholson; Simon Myers
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 3.  Autosomal-recessive forms of demyelinating Charcot-Marie-Tooth disease.

Authors:  O Dubourg; H Azzedine; C Verny; G Durosier; N Birouk; R Gouider; M Salih; A Bouhouche; A Thiam; D Grid; M Mayer; M Ruberg; M Tazir; A Brice; E LeGuern
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

4.  A new missense GDAP1 mutation disturbing targeting to the mitochondrial membrane causes a severe form of AR-CMT2C disease.

Authors:  Dagmara Kabzińska; Axel Niemann; Hanna Drac; Nina Huber; Anna Potulska-Chromik; Irena Hausmanowa-Petrusewicz; Ueli Suter; Andrzej Kochański
Journal:  Neurogenetics       Date:  2011-03-02       Impact factor: 2.660

5.  L239F founder mutation in GDAP1 is associated with a mild Charcot-Marie-Tooth type 4C4 (CMT4C4) phenotype.

Authors:  Dagmara Kabzińska; Halina Strugalska-Cynowska; Anna Kostera-Pruszczyk; Barbara Ryniewicz; Renata Posmyk; Alina Midro; Pavel Seeman; Lucia Báranková; Magdalena Zimoń; Jonathan Baets; Vincent Timmerman; Velina Guergueltcheva; Ivailo Tournev; Stayko Sarafov; Peter De Jonghe; Albena Jordanova; Irena Hausmanowa-Petrusewicz; Andrzej Kochański
Journal:  Neurogenetics       Date:  2010-03-16       Impact factor: 2.660

6.  WES homozygosity mapping in a recessive form of Charcot-Marie-Tooth neuropathy reveals intronic GDAP1 variant leading to a premature stop codon.

Authors:  Marion Masingue; Jimmy Perrot; Robert-Yves Carlier; Guenaelle Piguet-Lacroix; Philippe Latour; Tanya Stojkovic
Journal:  Neurogenetics       Date:  2018-02-02       Impact factor: 2.660

7.  Autosomal recessive forms of Charcot-Marie-Tooth disease.

Authors:  J M Vallat; D Grid; C Magdelaine; F Sturtz; M Tazir
Journal:  Curr Neurol Neurosci Rep       Date:  2004-09       Impact factor: 5.081

8.  Novel GDAP1 mutation in a Turkish family with CMT2K (CMT2K with novel GDAP1 mutation).

Authors:  Nilufer Sahin-Calapoglu; Meliha Tan; Mustafa Soyoz; Mustafa Calapoglu; Nurten Ozcelik
Journal:  Neuromolecular Med       Date:  2009-04-19       Impact factor: 3.843

9.  A novel GDAP1 Q218E mutation in autosomal dominant Charcot-Marie-Tooth disease.

Authors:  Ki Wha Chung; Seung Min Kim; Il Nam Sunwoo; Sun Young Cho; Su Jin Hwang; Joonki Kim; Sung Hee Kang; Kee-Duk Park; Kyoung-Gyu Choi; Il Saing Choi; Byung-Ok Choi
Journal:  J Hum Genet       Date:  2008-01-31       Impact factor: 3.172

10.  A new locus for autosomal dominant Charcot-Marie-Tooth disease type 2 (CMT2L) maps to chromosome 12q24.

Authors:  Bei-Sha Tang; Wei Luo; Kun Xia; Jian-Feng Xiao; Hong Jiang; Lu Shen; Jian-Guang Tang; Guo-Hua Zhao; Fang Cai; Qian Pan; He-Ping Dai; Qi-Dong Yang; Jia-Hui Xia; Oleg V Evgrafov
Journal:  Hum Genet       Date:  2004-03-12       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.